Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in Germany.

Abstract:

AIMS:To study age-related persistence in postmenopausal women with endocrine-responsive breast cancer treated with tamoxifen (TAM) and aromatase inhibitors (AI). METHODS:Data on 29,245 patients diagnosed with metastatic or non-metastatic breast cancer (BC) and initially treated with TAM or AI between 2004 and 2013 were included. The primary outcome measure was the age-dependent rate of discontinuation of endocrine treatment within 5years after initiation. Discontinuation of therapy was defined as a period of at least 90days without treatment. A multivariate Cox regression model was created to determine the influence of age on the risk of discontinuation. Health insurance type (private/statutory), type of care (gynecological/general), region (West/East Germany), concomitant diagnoses (depression, osteoporosis, and diabetes), and Charlson Comorbidity Score were included as covariates. RESULTS:The mean ages of the women in the <70 and ≥70 groups were 55.9 (SD: 9.7) and 77.4 (SD: 5.4) years, respectively. Within 5years after treatment initiation, 88.8% of women <70 of age and 82% of women ≥70 years of age had terminated treatment (p-value<0.001). Patients aged ≥70 exhibited a lower risk of treatment discontinuation than patients aged <70 (HR=0.75, 95% CI: 0.66-0.85). Furthermore, gynecological practices, disease management programs, and high Charlson scores increased persistence. CONCLUSIONS:Overall, the present study indicates that persistence rates are low in both women with BC aged <70 and those aged ≥70 years. We also found that younger women with BC are at a higher risk of treatment discontinuation than older women.

journal_name

J Geriatr Oncol

authors

Jacob L,Hadji P,Kostev K

doi

10.1016/j.jgo.2016.03.001

subject

Has Abstract

pub_date

2016-05-01 00:00:00

pages

169-75

issue

3

eissn

1879-4068

issn

1879-4076

pii

S1879-4068(16)30019-4

journal_volume

7

pub_type

杂志文章
  • Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies.

    abstract:BACKGROUND:The majority of patients with chronic lymphocytic leukemia (CLL) are older and have multiple comorbidities, including other cancer diagnoses. These patients are routinely excluded from participation in clinical trials. OBJECTIVE:In this phase II study, we determined the activity and toxicity of ofatumumab, ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.04.002

    authors: Vitale C,Falchi L,Ciccone M,Burger J,Pemmaraju N,Borthakur G,Wierda WG,Keating MJ,Ferrajoli A

    更新日期:2020-01-01 00:00:00

  • Older survivors of cancer in the COVID-19 pandemic: Reflections and recommendations for future care.

    abstract:PURPOSE:Although the year after cancer treatment is challenging for all cancer survivors, older adults (≥60 years) face additional challenges due to age-related decline and high rates of comorbidity. There is a paucity of research on how health service interruptions from the COVID-19 pandemic have impacted the experien...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.11.009

    authors: Haase KR,Kain D,Merchant S,Booth C,Koven R,Brundage M,Galica J

    更新日期:2020-12-03 00:00:00

  • Aromatase inhibitors: The unexpected breast cancer treatment.

    abstract:OBJECTIVE:Suboptimal adherence with endocrine treatment for breast cancer is influenced by a number of factors but remains poorly understood. We sought to describe the prior knowledge about and expectations of breast cancer treatments among older women retrospecting on their diagnosis and treatment. METHODS:Thematic a...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.024

    authors: Pieters HC,Green E,Sleven M,Stanton AL

    更新日期:2020-04-01 00:00:00

  • Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301).

    abstract:OBJECTIVES:We evaluated the impact of age in a randomized phase II trial that compared three first-line drugs in elderly patients with advanced non-small cell lung cancer (NSCLC) and a poor performance status (PS). MATERIALS AND METHODS:Patients with advanced NSCLC with a PS of 2 or 3 were enrolled into a multicenter ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.jgo.2015.02.002

    authors: Des Guetz G,Landre T,Westeel V,Milleron B,Vaylet F,Urban T,Barlesi F,Souquet PJ,Debieuvre D,Braun D,Fraboulet G,Monnet I,Uzzan B,Molinier O,Morin F,Moro-Sibilot D,Morère JF

    更新日期:2015-05-01 00:00:00

  • Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer.

    abstract:OBJECTIVES:Older patients with cancer have increased risk for comorbidity, polypharmacy (PP) and drug related problems (DRP). The aim of this study was to assess the effect of a clinical pharmacist and geriatrician medication review (MR) among older outpatients with cancer to optimize management of comorbidities during...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.07.010

    authors: Choukroun C,Leguelinel-Blache G,Roux-Marson C,Jamet C,Martin-Allier A,Kinowski JM,Le Guillou C,Richard H,Antoine V

    更新日期:2021-01-01 00:00:00

  • How (and why) to ask the older cancer patient about sexual health and sexual minority status.

    abstract::Sexual health and sexual minority status are often undiscussed during oncology visits. Yet, these topics should be addressed in older cancer patients in order to help mitigate the sexual side effects of cancer treatment and to acknowledge - and, at times, help provide - the social support older patients need during th...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2019.08.003

    authors: Cathcart-Rake E,O'Connor JM,Jacobson A,McGuire L,Jatoi A

    更新日期:2020-05-01 00:00:00

  • Patterns of care and treatment outcomes in patients age 80 or older with non-metastatic pancreatic cancer.

    abstract:INTRODUCTION:Older adults are underrepresented in landmark trials that determine treatment guidelines for pancreatic cancer. We used the National Cancer Database (NCDB) to compare treatment patterns and outcomes in stage I-III pancreatic cancer between older adult patients, defined as age 80 or older, to patients young...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.12.006

    authors: Li R,Vazquez J,Novak J,Sedrak M,Warner S,Glaser S,Chen YJ,Dale W,Amini A

    更新日期:2020-05-01 00:00:00

  • Patient-reported and objectively measured physical function in older breast cancer survivors and cancer-free controls.

    abstract:OBJECTIVES:Older breast cancer survivors (BCS) consistently report more functional limitations than women without cancer, but whether or not these differences remain when using objective measures of physical functioning and the correlates of these measures is unknown. METHODS:Cross-sectional study comparing older (≥60...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.10.006

    authors: Winters-Stone KM,Medysky ME,Savin MA

    更新日期:2019-03-01 00:00:00

  • Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women.

    abstract:OBJECTIVE:To assess adjuvant chemotherapy recommendations, administration and disease-specific survival for invasive breast cancer (BC) among patients 75years and older compared with that of younger women. MATERIALS AND METHODS:A cohort of patients with primary breast cancer, aged 65-94, stages I-III from 1990 to 2010...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.12.007

    authors: Kaplan HG,Malmgren JA,Atwood MK

    更新日期:2013-04-01 00:00:00

  • Systematic review of falls in older adults with cancer.

    abstract:OBJECTIVES:Older adults frequently experience falls, at great cost to themselves and society. Older adults with cancer may be at greater risk for falls and have unique risk factors. MATERIALS AND METHODS:We undertook a systematic review of the available medical literature to examine the current evidence regarding fact...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2014.10.003

    authors: Wildes TM,Dua P,Fowler SA,Miller JP,Carpenter CR,Avidan MS,Stark S

    更新日期:2015-01-01 00:00:00

  • Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort.

    abstract:OBJECTIVE:Clinical trials investigating breast cancer treatment often exclude or misrepresent older adults. This study compares treatment patterns and survival of older women diagnosed with breast cancer between a Dutch and a British observational cohort. MATERIALS AND METHODS:Women aged 70 years and older diagnosed w...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.05.004

    authors: Schuil H,Derks M,Liefers GJ,Portielje J,van de Velde C,Syed B,Green A,Ellis I,Cheung KL,Bastiaannet E

    更新日期:2018-11-01 00:00:00

  • Effect of advanced age on peri-operative outcomes after robotic-assisted pulmonary lobectomy: Retrospective analysis of 287 consecutive cases.

    abstract:OBJECTIVES:We investigated whether advanced age affects peri-operative outcomes after robotic-assisted pulmonary lobectomies. MATERIALS AND METHODS:We retrospectively analyzed patients who underwent robotic-assisted lobectomy by one surgeon over a 5-year period. Rates of postoperative complications were compared accor...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2016.11.003

    authors: Kass KS,Velez-Cubian FO,Zhang WW,Toosi K,Tanvetyanon T,Rodriguez KL,Thau MR,Garrett JR,Moodie CC,Fontaine JP,Toloza EM

    更新日期:2017-03-01 00:00:00

  • The geriatrician's perspective on practical aspects of the multidisciplinary care of older adults with cancer.

    abstract::Multidisciplinary teams (MDTs) have been incorporated into the practical care of elderly patients with cancer. Several geriatric oncology centres have attempted to determine the best way to implement MDTs by using geriatric assessment (GA). Developing a geriatric oncology service is a feasible work, which requires sig...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2016.07.001

    authors: Karnakis T,Gattás-Vernaglia IF,Saraiva MD,Gil-Junior LA,Kanaji AL,Jacob-Filho W

    更新日期:2016-09-01 00:00:00

  • Delirium incidence, risk factors, and treatments in older adults receiving chemotherapy: A systematic review and meta-analysis.

    abstract:INTRODUCTION:Older adults with cancer are at increased risk of delirium due to age, comorbidities, medications, cognitive impairment, and possibly cancer treatments. However, there is scant information on the risks of delirium with chemotherapy and approaches to prevent or treat it. We performed a systematic review and...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.08.011

    authors: Jung P,Puts M,Frankel N,Syed AT,Alam Z,Yeung L,Malik U,Rosario C,Ayala AP,Hudson J,Alibhai SMH

    更新日期:2020-09-14 00:00:00

  • Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer.

    abstract:INTRODUCTION:Cognitive impairment (CI) increases chemotherapy toxicity risk with need to understand this association utilizing publicly available short screening tools. We evaluated this utilizing a lower threshold on a short screening tool in older adults with cancer. MATERIALS AND METHODS:We analyzed data from the C...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.10.004

    authors: Jayani RV,Magnuson AM,Sun CL,Ma H,Tew WP,Mohile SG,Gajra A,Klepin HD,Gross CP,Muss HB,Chapman AE,Katheria V,Hurria A,Dale W

    更新日期:2020-03-01 00:00:00

  • Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort.

    abstract:BACKGROUND:Because of comorbidities and polypharmacy, older patients with cancer have a greater risk of iatrogenic events. We aimed to characterize potential drug-drug interactions (PDIs) and the risk of unplanned hospitalization in older patients with cancer treated with antineoplastic agents (ANAs). METHODS:We analy...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.023

    authors: Beinse G,Reitter D,Segaux L,Carvahlo-Verlinde M,Rousseau B,Tournigand C,Cudennec T,Laurent M,Boudou-Rouquette P,Paillaud E,Canouï-Poitrine F,Caillet P,ELCAPA Study Group.

    更新日期:2020-05-01 00:00:00

  • Surgical management of metastatic colon cancer: A population-based analysis.

    abstract:BACKGROUND:Metastasectomy has a curative potential in colon cancer, but its benefits have not been ascertained in population data. Our objective was to evaluate utilization of metastasectomy in colon cancer and its survival outcomes in groups defined by different age at diagnosis, tumor grade or varying extent of nodal...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2015.08.002

    authors: Khan H,Khan N,Ahmad A,Olszewski AJ,Somasundar P

    更新日期:2015-11-01 00:00:00

  • Management and supportive treatment of frail patients with metastatic pancreatic cancer.

    abstract::Data regarding management of frail patients with pancreatic ductal adenocarcinoma practice is currently very scarce. Randomized clinical trials usually exclude these subgroup of patients and the majority of the publications only consider chronological age and ECOG performance status for their classification. Therefore...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.06.005

    authors: Macarulla T,Carrato A,Díaz R,García A,Laquente B,Sastre J,Álvarez R,Muñoz A,Hidalgo M

    更新日期:2019-05-01 00:00:00

  • Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care.

    abstract:BACKGROUND:An oncogeriatric approach may affect management of elderly patients with breast cancer. However, little is known about oncogeriatric care in the metastatic setting. Therefore, we performed an international comparison of management of elderly patients with primary metastatic disease who were treated in two di...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.jgo.2014.02.005

    authors: van de Water W,Bastiaannet E,Egan KM,de Craen AJ,Westendorp RG,Balducci L,van de Velde CJ,Liefers GJ,Extermann M

    更新日期:2014-07-01 00:00:00

  • Patient-reported psychosocial needs and psychological distress predict survival in geriatric oncology patients.

    abstract:OBJECTIVES:Little is known about how psychosocial factors and distress affect older patients with cancer and their survival. The study goals were to: 1) observe the prevalence of anxiety (ANX) and depression (DEP) symptoms at diagnosis in patients aged ≥65 years, 2) observe the association between social isolation (iso...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.10.001

    authors: Leung B,Shokoohi A,Bates A,Ho C

    更新日期:2020-11-04 00:00:00

  • Activities, function, and health-related quality of life (HRQOL) of older adults with cancer.

    abstract:OBJECTIVE:This study aims to (1) describe the activities, function, and health-related quality of life (HRQOL) of a large sample of older adults (age ≥65) with cancer, (2) identify the associations with demographics, cancer type, comorbid conditions, and ability to participate in activities and functional status. MATE...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2017.02.009

    authors: Pergolotti M,Deal AM,Williams GR,Bryant AL,Bensen JT,Muss HB,Reeve BB

    更新日期:2017-07-01 00:00:00

  • Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.

    abstract::BACKGROUND: The current study was undertaken to explore whether older age predicts adverse event rates in metastatic melanoma patients participating in cancer clinical trials. METHODS: Six phase II studies conducted at our institution for patients with metastatic disease were used in these pooled analyses: 1) ABT-510...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.04.002

    authors: Jatoi A,Allred JB,Suman VJ,Creagan ET,Croghan GA,Amatruda T,Markovic SN

    更新日期:2012-10-01 00:00:00

  • Predictive value of each geriatric assessment domain for older patients with cancer: A systematic review.

    abstract:BACKGROUND:A geriatric assessment (GA) is increasingly used to help guide treatment decisions in older patients with cancer. However, there is no consensus regarding which domains should be included in the GA. In addition, the field of geriatric oncology moves very fast and as a result many new studies have been publis...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.02.010

    authors: Bruijnen CP,van Harten-Krouwel DG,Koldenhof JJ,Emmelot-Vonk MH,Witteveen PO

    更新日期:2019-11-01 00:00:00

  • The acceleration of ageing in older patients with cancer.

    abstract::Older cancer survivors may experience ageing at an accelerated rate when compared to their similar-aged, cancer-free counterparts. Ageing is undoubtedly a significant risk factor for cancer. There is evidence to suggest, however, that this relationship may in fact be bidirectional, with cancer and its treatments contr...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2020.09.010

    authors: Muhandiramge J,Orchard S,Haydon A,Zalcberg J

    更新日期:2020-09-12 00:00:00

  • Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD.

    abstract:BACKGROUND:Regorafenib significantly increases overall survival (OS) in patients with metastatic colorectal cancer previously treated but gives toxicities. OBJECTIVES:to assess the efficacy and safety of regorafenib at it's approved dose in the older population. PATIENTS AND METHODS:This multicenter single-arm phase ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.04.001

    authors: Aparicio T,Darut-Jouve A,Khemissa Akouz F,Montérymard C,Artru P,Cany L,Romano O,Valenza B,Le Foll C,Delbaldo C,Falandry C,Norguet Monnereau E,Ben Abdelghani M,Smith D,Rinaldi Y,Père Verge D,Baize N,Maillard E,Dohan A

    更新日期:2020-11-01 00:00:00

  • The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer.

    abstract:OBJECTIVE:Sarcopenia is associated with poor outcomes in patients undergoing surgery for pancreatic ductal adenocarcinoma (PDAC). However, few studies have assessed changes in sarcopenia during multimodality therapy or its effect on overall survival (OS). METHODS:Computed tomography (CT) total psoas area index (TPAI) ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.03.002

    authors: Benjamin AJ,Buschmann MM,Zhang SQ,Wroblewski K,Kindler HL,Roggin KK,Dale W

    更新日期:2018-07-01 00:00:00

  • Survival benefit of statins in older patients with rectal cancer: A Swedish population-based cohort study.

    abstract:OBJECTIVES:Increasing evidence suggests that statins may have antitumor effects but their role in rectal cancer appears inconclusive. The aim of this study was to investigate whether statins may have an impact on survival of older and younger patients with rectal cancer. MATERIALS AND METHODS:This study included 238 p...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.01.011

    authors: Kotti A,Holmqvist A,Albertsson M,Sun XF

    更新日期:2019-09-01 00:00:00

  • Treatment of older patients with advanced non-small cell lung cancer: A challenge.

    abstract::With a median age of 70 years at diagnosis, lung cancer is a disease of older persons. As a consequence oncologists are confronted with an increasing older lung cancer population for which treatment decisions are needed. In the past years, the therapeutic landscape of advanced non-small cell lung cancer (NSCLC) has ch...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.09.008

    authors: Decoster L,Schallier D

    更新日期:2019-07-01 00:00:00

  • Comprehensive Geriatric Assessment (CGA) based risk factors for increased caregiver burden among elderly Asian patients with cancer.

    abstract:OBJECTIVE:This study aims to identify Comprehensive Geriatric Assessment (CGA) based risk factors to help predict caregiver burden among elderly patients with cancer. MATERIALS AND METHOD:The study evaluated 249 patients newly diagnosed with cancer, aged 70years and above, who attended the geriatric oncology clinic at...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2016.03.003

    authors: Rajasekaran T,Tan T,Ong WS,Koo KN,Chan L,Poon D,Roy Chowdhury A,Krishna L,Kanesvaran R

    更新日期:2016-05-01 00:00:00

  • The relevance of geriatric assessment for older patients receiving palliative chemotherapy.

    abstract:OBJECTIVES:No tools accurately discriminate between older patients who are fit and those who are frail to tolerate systemic palliative treatment. This study evaluates whether domains of geriatric assessment (GA) are associated with increased risk of chemotherapy intolerance in patients who were considered fit to start ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.05.016

    authors: van der Vlies E,Kurk SA,Roodhart JML,Gerritse FL,Pelgrim TC,Vos JM,Sohne M,Hunting CB,Noordzij PG,van der Velden AMT,Los M

    更新日期:2020-04-01 00:00:00